Cargando…
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma
SIMPLE SUMMARY: In this study, we investigated how frequently and how early circulating tumor cells (CTCs) were identified prior to the surveillance imaging detection of melanoma progression. This paper reports the results from 325 stage III melanoma patients from a prospective, IRB-approved study a...
Autores principales: | Lucci, Anthony, Addanki, Sridevi, Chiang, Yi-Ju, Meas, Salyna, Sarli, Vanessa N., Upshaw, Joshua R., Manchem, Mayank, Patel, Sapna P., Wargo, Jennifer A., Gershenwald, Jeffrey E., Ross, Merrick I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377914/ https://www.ncbi.nlm.nih.gov/pubmed/37509290 http://dx.doi.org/10.3390/cancers15143630 |
Ejemplares similares
-
Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
por: Addanki, Sridevi, et al.
Publicado: (2022) -
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
por: Anand, Kartik, et al.
Publicado: (2019) -
Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer
por: Singh, Balraj, et al.
Publicado: (2023) -
Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: A randomized controlled trial (NCT00506311)
por: Mortenson, Melinda M, et al.
Publicado: (2008) -
Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine
por: Singh, Balraj, et al.
Publicado: (2021)